Post-approval studies (Phase 4)Not Yet RecruitingNCT05487950
What this trial is testing
Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk
Who this might be right for
Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)
Assistance Publique - Hôpitaux de Paris 550